OSR Health, Inc. (OSRHW) stock
OSRHWOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as OSRH
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $325.06KP/E –Yield –
OSR Health r&d expenses
Research and development expenses are spending on new products and technology.
OSR Health's R&D Expenses for the twelve months ending Dec 31, 2025 was $318.45K, up 97.6% year over year. For fiscal 2025 it was $318.45K, up 97.6% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $318.45K | +97.6% |
| FY2024 | Dec 31, 2024 | $161.16K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $94.63K | +5.0% |
| Q1 FY2026 | Mar 31, 2026 | $113.15K | +681.6% |
| Q4 FY2025 | Dec 31, 2025 | $176.57K | +222.8% |
| Q2 FY2025 | Jun 30, 2025 | $53.53K | +18.3% |
| Q1 FY2025 | Mar 31, 2025 | $90.15K | +93.0% |
| Q4 FY2024 | Dec 31, 2024 | $14.48K | – |
| Q3 FY2024 | Sep 30, 2024 | $54.71K | – |
| Q2 FY2024 | Jun 30, 2024 | $45.26K | – |
| Q1 FY2024 | Mar 31, 2024 | $46.72K | – |